HHLA2 and neoplasm: Although no specific studies exist for HHLA2 in this situation, patients with high HHLA2 expression may be more sensitive to chemotherapy and have better responses to immunotherapy, indicating that HHLA2 might play a role in modulating the tumor’s response to chemotherapeutic agents (Ding et al. 2022).